Skip to content

Clinical trials

Phase 2 Neutropenia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neutropenia Phase: Phase 2 Country / region: Canada Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
National Cancer Institute (NCI)1
St. Justine's Hospital1
University of Manitoba1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neutropenia4
Acquired Immunodeficiency Syndrome1
Cytopenia1
HIV Infections1
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Myeloproliferative Disorders1
Neuroectodermal Tumors, Primitive, Peripheral1
Sarcoma1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.